109 related articles for article (PubMed ID: 28132769)
1. Immunosuppression in sheep induced by cyclophosphamide, bluetongue virus and their combination: Effect on clinical reaction and viremia.
Chatzinasiou E; Chaintoutis SC; Dovas CI; Papanastassopoulou M; Papadopoulos O
Microb Pathog; 2017 Mar; 104():318-327. PubMed ID: 28132769
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8.
Sánchez-Cordón PJ; Pérez de Diego AC; Gómez-Villamandos JC; Sánchez-Vizcaíno JM; Pleguezuelos FJ; Garfia B; del Carmen P; Pedrera M
Vet Microbiol; 2015 May; 177(1-2):95-105. PubMed ID: 25769647
[TBL] [Abstract][Full Text] [Related]
3. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune response of sheep to bluetongue virus.
Ghalib HW; Cherrington JM; Adkison MA; Osburn BI
Prog Clin Biol Res; 1985; 178():489-96. PubMed ID: 2989890
[TBL] [Abstract][Full Text] [Related]
5. Temporal relationships of viremia, interferon activity, and antibody responses of sheep infected with several bluetongue virus strains.
Foster NM; Luedke AJ; Parsonson IM; Walton TE
Am J Vet Res; 1991 Feb; 52(2):192-6. PubMed ID: 1707246
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle.
Ellis JA; Luedke AJ; Davis WC; Wechsler SJ; Mecham JO; Pratt DL; Elliott JD
Vet Immunol Immunopathol; 1990 Jan; 24(1):49-67. PubMed ID: 2156375
[TBL] [Abstract][Full Text] [Related]
8. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
9. Bluetongue virus-induced interferon in cattle.
MacLachlan NJ; Thompson J
Am J Vet Res; 1985 Jun; 46(6):1238-41. PubMed ID: 2411172
[TBL] [Abstract][Full Text] [Related]
10. Virological, clinical and serological responses of sheep infected with tissue culture adapted bluetongue virus serotypes 10, 11, 13 and 17.
Ghalib HW; Cherrington JM; Osburn BI
Vet Microbiol; 1985 Jan; 10(2):179-88. PubMed ID: 2580386
[TBL] [Abstract][Full Text] [Related]
11. Bluetongue virus serotype 26: infection kinetics and pathogenesis in Dorset Poll sheep.
Batten CA; Henstock MR; Bin-Tarif A; Steedman HM; Waddington S; Edwards L; Oura CA
Vet Microbiol; 2012 May; 157(1-2):119-24. PubMed ID: 22177889
[TBL] [Abstract][Full Text] [Related]
12. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
13. Bluetongue virus serotypes 20 and 17 infections in sheep: comparison of clinical and serological responses.
Groocock CM; Parsonson IM; Campbell CH
Vet Microbiol; 1982 Jul; 7(3):189-96. PubMed ID: 6287703
[TBL] [Abstract][Full Text] [Related]
14. Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
Stewart M; Dubois E; Sailleau C; Bréard E; Viarouge C; Desprat A; Thiéry R; Zientara S; Roy P
Vaccine; 2013 Jan; 31(3):553-8. PubMed ID: 23159460
[TBL] [Abstract][Full Text] [Related]
15. Virological and pathological findings in Bluetongue virus serotype 8 infected sheep.
Worwa G; Hilbe M; Chaignat V; Hofmann MA; Griot C; Ehrensperger F; Doherr MG; Thür B
Vet Microbiol; 2010 Aug; 144(3-4):264-73. PubMed ID: 20153937
[TBL] [Abstract][Full Text] [Related]
16. Immunologic response of sheep to inactivated and virulent bluetongue virus.
Stott JL; Barber TL; Osburn BI
Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and immuno-suppression in sheep infected with bluetongue virus serotype-23.
Umeshappa CS; Singh KP; Nanjundappa RH; Pandey AB
Vet Microbiol; 2010 Aug; 144(3-4):310-8. PubMed ID: 20347236
[TBL] [Abstract][Full Text] [Related]
18. Duration of bluetongue viraemia and serological responses in experimentally infected European breeds of sheep and goats.
Koumbati M; Mangana O; Nomikou K; Mellor PS; Papadopoulos O
Vet Microbiol; 1999 Feb; 64(4):277-85. PubMed ID: 10063533
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
[TBL] [Abstract][Full Text] [Related]
20. Specific T-cell subsets have a role in anti-viral immunity and pathogenesis but not viral dynamics or onwards vector transmission of an important livestock arbovirus.
Newbrook K; Khan N; Fisher A; Chong K; Gubbins S; Davies WC; Sanders C; Busquets MG; Cooke L; Corla A; Ashby M; Flannery J; Batten C; Stokes JE; Sanz-Bernardo B; Carpenter S; Moffat K; Darpel KE
Front Immunol; 2024; 15():1328820. PubMed ID: 38357545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
